BIOVICA INTERNATIONAL AB SER. B revenue for the last year amounted to 3.00 M SEK, the most of which — 3.38 M SEK — came from its highest performing source at the moment, Blood-based Biomarker Assays, the year earlier bringing 2.04 M SEK. The greatest contribution to the revenue figure was made by United States — last year it brought BIOVICA INTERNATIONAL AB SER. B 3.26 M SEK, and the year before that — 1.94 M SEK.